May 11, 2026 07:12AM
May 6, 2026 08:04AM
May 6, 2026 08:00AM
Apr 29, 2026 08:00AM
Mar 2, 2026 08:40AM
Mar 2, 2026 08:04AM
Mar 2, 2026 08:00AM UroGen Announces ZUSDURI™ Launch is On-Track and Reports Fourth Quarter and Full Year 2025 Financial Results
Feb 23, 2026 08:00AM
Nov 6, 2025 08:21AM
Nov 6, 2025 08:00AM
Oct 30, 2025 08:00AM
Aug 11, 2025 06:39AM
Aug 8, 2025 08:33AM
Aug 7, 2025 08:16AM UroGen Pharma (URGN) Misses Q2 EPS by 22c
Aug 7, 2025 08:00AM
Jul 29, 2025 08:00AM
May 12, 2025 08:02AM
May 12, 2025 08:00AM
May 1, 2025 04:00PM
Mar 11, 2025 06:42AM
Mar 10, 2025 08:03AM UroGen Pharma (URGN) Misses Q4 EPS by 3c
Mar 10, 2025 08:00AM
Feb 27, 2025 08:00AM
Nov 6, 2024 08:03AM
Nov 6, 2024 08:00AM
Oct 30, 2024 08:00AM
Aug 13, 2024 08:02AM
Aug 13, 2024 08:00AM UroGen Pharma Ahead of Schedule to Complete UGN-102 NDA Submission and Reports 2024 Second Quarter Financial Results and Business Highlights
Aug 5, 2024 08:00AM
Jul 23, 2024 09:19AM
May 13, 2024 08:04AM
May 13, 2024 08:00AM
May 3, 2024 08:00AM
Mar 14, 2024 08:03AM
Mar 14, 2024 08:00AM UroGen Pharma Delivers Double Digit JELMYTO® Growth and Prepares for the Next Phase of the Company with on Track Rolling Submission of UGN-102
Mar 4, 2024 08:00AM
Nov 14, 2023 08:01AM
Nov 14, 2023 08:00AM
Nov 7, 2023 08:00AM
Aug 10, 2023 08:03AM
Aug 10, 2023 08:00AM
Aug 2, 2023 05:00PM UroGen Pharma to Report Second Quarter 2023 Financial Results on Thursday, August 10, 2023
May 11, 2023 08:25AM
May 11, 2023 08:00AM
May 4, 2023 08:00AM
Mar 16, 2023 08:08AM
Mar 16, 2023 08:00AM
Mar 9, 2023 04:00PM
Nov 10, 2022 08:09AM UroGen Pharma (URGN) Tops Q3 EPS by 3c
Nov 10, 2022 08:00AM

1,199,636 total articles have been posted to this entity.

Click Here to Sign-Up for StreetInsider.com Premium to View All